title: Deletion of ABH blood group isoantigen and prognosis in patients with transitional cell bladder carcinoma.
authors.affiliation: Department of Urology, University Hospital, Uppsala, Sweden.
authors.forename: P U
authors.initials: PU
authors.lastname: Malmström
authors.forename: C
authors.initials: C
authors.lastname: Busch
authors.forename: B J
authors.initials: BJ
authors.lastname: Norlen
mesh_terms: D000017:ABO Blood-Group System; D002295:Carcinoma, Transitional Cell / Q000097:blood* / Q000401:mortality; D005500:Follow-Up Studies; D006801:Humans; D011379:Prognosis; D012189:Retrospective Studies; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000097:blood* / Q000401:mortality
chemical_list: D000017:ABO Blood-Group System